IRIS
VETRANO, ERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.021
AS - Asia 920
NA - Nord America 636
SA - Sud America 142
AF - Africa 12
Totale 2.731
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 616
RU - Federazione Russa 582
SG - Singapore 311
CN - Cina 234
HK - Hong Kong 158
IT - Italia 155
IE - Irlanda 130
BR - Brasile 113
KR - Corea 70
VN - Vietnam 47
DE - Germania 44
IN - India 42
GB - Regno Unito 30
FR - Francia 18
JP - Giappone 13
MX - Messico 12
FI - Finlandia 8
AR - Argentina 7
AT - Austria 7
SE - Svezia 7
CO - Colombia 6
EG - Egitto 6
ID - Indonesia 6
PK - Pakistan 6
PL - Polonia 6
TR - Turchia 6
CA - Canada 5
VE - Venezuela 5
BD - Bangladesh 4
NL - Olanda 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
LT - Lituania 3
PE - Perù 3
ZA - Sudafrica 3
BE - Belgio 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
MA - Marocco 2
MO - Macao, regione amministrativa speciale della Cina 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
UA - Ucraina 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
IQ - Iraq 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.731
Salva come PNG Salva come JPEG
Città #
Moscow 196
Hong Kong 157
Singapore 151
Dublin 124
Santa Clara 99
Chandler 81
Hefei 70
Seoul 70
The Dalles 62
New York 41
Naples 38
Ashburn 34
Bengaluru 30
Beijing 25
Dallas 25
Ho Chi Minh City 19
Munich 17
São Paulo 13
Los Angeles 12
Cambridge 11
Princeton 11
Roxbury 11
Caserta 10
Falkenstein 10
Salerno 8
Liveri 7
Atlanta 6
Bremen 6
Hanoi 6
Stockholm 6
Chennai 5
Florence 5
Lahore 5
Milan 5
Belo Horizonte 4
Brooklyn 4
Damietta 4
Denver 4
Des Moines 4
Helsinki 4
Istanbul 4
Mexico City 4
Paris 4
Vienna 4
Amsterdam 3
Andover 3
Baku 3
Bexley 3
Boydton 3
Can Tho 3
Chengdu 3
Dhaka 3
Guarulhos 3
Guayaquil 3
Houston 3
Lappeenranta 3
Manaus 3
Mumbai 3
Norwalk 3
Nuremberg 3
Rio de Janeiro 3
Seattle 3
Shenzhen 3
Terzigno 3
Toronto 3
Warsaw 3
Zurich 3
Asunción 2
Athens 2
Avellino 2
Banda Aceh 2
Bari 2
Belgrade 2
Bishkek 2
Biên Hòa 2
Boardman 2
Bogotá 2
Boston 2
Brasília 2
Brno 2
Brussels 2
Buenos Aires 2
Cagliari 2
Camden 2
Campinas 2
Da Nang 2
Ecatepec 2
Frankfurt am Main 2
Guastalla 2
Honolulu 2
Itabira 2
Jacksonville 2
Johannesburg 2
La Paz 2
Lisbon 2
Londrina 2
Loreto Aprutino 2
Macao 2
Malang 2
Manchester 2
Totale 1.551
Salva come PNG Salva come JPEG
Nome #
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 110
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 108
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 104
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 95
null 93
Cardiovascular benefits from gliflozins: Effects on endothelial function 91
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 88
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 86
HCC and molecular targeting therapies: Back to the future 85
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 84
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 84
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 81
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 80
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 77
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 74
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 71
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 70
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 68
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 67
Editorial - Direct-acting antivirals therapy in HCV patients with HCC: lights and shadow 67
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 66
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 65
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 64
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 64
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 63
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 62
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 61
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 57
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 57
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 56
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 55
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 55
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 54
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 50
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 44
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice 44
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 39
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 39
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 37
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 33
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 26
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 20
Totale 2.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 1 0 1 0 0 2 10
2021/202294 1 0 0 17 20 6 4 2 3 2 11 28
2022/2023292 17 15 8 17 35 16 4 22 133 8 5 12
2023/2024234 31 11 6 18 47 36 4 9 5 15 22 30
2024/2025712 6 13 3 11 103 76 102 68 133 65 59 73
2025/20261.448 193 234 199 118 318 386 0 0 0 0 0 0
Totale 2.794